Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P Mult Scler. 2012 May 8. PMID: 22570359. Abstract CommentRecommendBookmarkWatch